M&A Deal Summary

Thermo Fisher Scientific Acquires Affinity BioReagents

On July 17, 2008, Thermo Fisher Scientific acquired life science company Affinity BioReagents

Acquisition Highlights
  • This is Thermo Fisher Scientific’s 8th transaction in the Life Science sector.
  • This is Thermo Fisher Scientific’s 16th transaction in the United States.
  • This is Thermo Fisher Scientific’s 1st transaction in Colorado.

M&A Deal Summary
Date 2008-07-17
Target Affinity BioReagents
Sector Life Science
Buyer(s) Thermo Fisher Scientific
Deal Type Add-on Acquisition

Target

Affinity BioReagents

Golden, Colorado, United States
Affinity BioReagents, Inc., is a provider of antibodies, peptides, proteins and other reagents for life science research, based in Golden, Colorado. Affinity BioReagents has an offering of more than 35,000 reagents - primarily monoclonal and polyclonal antibodies - which are used in numerous fields of medical and academic research, as well as drug discovery. The company also provides recombinant proteins and custom antibody-production services.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Thermo Fisher Scientific

Waltham, Massachusetts, United States
Category Company
Founded 1956
Sector Test/Measurement Equipment
Employees122,000
Revenue 42.9B USD (2023)
DESCRIPTION
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.

Thermo Scientific is a provider of analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 20 of 62
Sector (Life Science) 8 of 23
Type (Add-on Acquisition) 18 of 55
State (Colorado) 1 of 2
Country (United States) 16 of 38
Year (2008) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-01 Open Biosystems

Huntsville, Alabama, United States

Open Biosystems, Inc. develops, manufactures and markets genomic research tools to scientists and researchers in corporate, academic and government laboratories. These research tools provide investigators with standardized high-quality genes, RNAi and antibodies for interrogating gene function in relation to oncology, neuroscience and metabolic disorders.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-01 Afora SA

Barcelona, Spain

Afora SA is a manufacturer and distributor of laboratory equipment and consumables.

Buy -
Mergr

Product

Company

Legal